Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners

被引:15
|
作者
Cuenca-Barrales, Carlos [1 ,2 ]
Montero-Vilchez, Trinidad [1 ,2 ]
Krajewski, Piotr K. [3 ]
Szepietowski, Jacek C. [3 ]
Matusiak, Lukasz [3 ]
Arias-Santiago, Salvador [1 ,2 ,4 ]
Molina-Leyva, Alejandro [1 ,2 ]
机构
[1] Hosp Univ Virgen Nieves, Dermatol Dept, Hidradenitis Suppurat Clin, Granada 18014, Spain
[2] Inst Invest Biosanit ibs, TECe19 Dermatol Clin & Traslac Invest Grp, GRANADA, Granada 18012, Spain
[3] Wroclaw Med Univ, Dept Dermatol, Venereol & Allergol, PL-50368 Wroclaw, Poland
[4] Univ Granada, Sch Med, Dept Dermatol, Granada 18016, Spain
关键词
hidradenitis suppurativa; quality of life; sexual dysfunction; erectile dysfunction; sexual partners; FAMILY-MEMBERS; INDEX; MULTICENTER; IMPAIRMENT; VALIDATION; DISEASE; VERSION; IMPACT;
D O I
10.3390/ijerph20010389
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Hidradenitis suppurativa (HS) is a chronic skin disease that profoundly affects patients' quality of life (QoL) and sexuality. Few data are available on the impact of HS on patients' partners. We aimed to explore the QoL and sexual function of patients' partners and the factors associated with their impairment and to compare the QoL and sexual function of single patients and those in a stable relationship. We conducted a cross-sectional study at Hospital Universitario Virgen de las Nieves (Granada, Spain) and at the Wroclaw Medical University (Wroclaw, Poland). Patients over the age of 16 years attending their scheduled follow-up and their partners, if any, were included. The Dermatology Life Quality Index (DLQI) and the Family Dermatology Life Quality Index (FDLQI) were used to estimate the QoL of patients and partners, respectively. The FSFI-6 was used to determine sexual dysfunction in women and the IIEF-5 for erectile dysfunction in men. Thirty-four single patients and twenty-eight patients in a stable relationship and their partners were included. Patients had a very large impact (DLQI 12.5 +/- 7.5) and their partners a moderate impact (FDLQI 10.3 +/- 7.1) in their QoL due to HS. Women with HS had a high prevalence of sexual dysfunction (13/32, 40.6%) and men of erectile dysfunction (19/30, 63.3%). Male partners also had a high prevalence of erectile dysfunction (10/17, 58.8%), while only one female partner had sexual dysfunction (1/11, 9.1%). Factors related to disease severity, intensity of symptoms and body mass index were associated with poorer QoL in partners and time of disease evolution with greater erectile dysfunction in male partners. In conclusion, HS not only profoundly affects the QoL and sexuality of patients but also of their partners. Several risk factors have been identified, which should be taken into account in the holistic approach of the disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Incidence of sexual dysfunction among patients with hidradenitis suppurativa: a population-based retrospective analysis
    Slyper, M.
    Strunk, A.
    Garg, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) : 502 - 503
  • [42] Hidradenitis suppurativa leads to a profound impairment in quality of life
    Schneider-Burrus, S.
    Tsaousi, A.
    Sabat, R.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E31 - E31
  • [43] Impact of individual lesions of hidradenitis suppurativa in the quality of life
    Mouktaroudi, Maria
    Tzanetakou, Vassiliki
    Micha, Styliani
    Bolanou, Amalia
    Kanni, Theodora
    Rellou, Sofia
    Giamarellos-Bourboulis, Evangelos J.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 36 - 36
  • [44] The impact of Janus kinase 1 inhibitors on quality of life in patients with hidradenitis suppurativa
    Ring, Hans Christian
    Thomsen, Simon F.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (02) : 274 - 274
  • [45] Hidradenitis suppurativa in Saudi Arabia, quality of life measures
    Binamer, Yousef
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 63 - 63
  • [46] Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study
    Janse, I. C.
    Deckers, I. E.
    van der Maten, A. D.
    Evers, A. W. M.
    Boer, J.
    van der Zee, H. H.
    Prens, E. P.
    Horvath, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (04) : 1042 - 1047
  • [47] Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa
    Kirby, J. S.
    Hereford, B.
    Thorlacius, L.
    Villumsen, B.
    Ingram, J. R.
    Garg, A.
    Butt, M.
    Esmann, S.
    King, T.
    Tan, J.
    Jemec, G. B. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (04) : 681 - 687
  • [48] Fear of negative evaluation in hidradenitis suppurativa patients is correlated with worse quality of life
    Singh, R.
    Senthilnathan, A.
    Richardson, I. M.
    Kaplan, S. G.
    Feldman, S. R.
    Pichardo, R. O.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S63 - S63
  • [49] Quality of life in patients with early- and late-onset hidradenitis suppurativa
    F. Sampogna
    L. Fania
    S. Mastroeni
    R. Fusari
    A. Panebianco
    D. Abeni
    Archives of Dermatological Research, 2023, 315 : 473 - 479
  • [50] Even mild hidradenitis suppurativa impairs quality of life
    Senthilnathan, A.
    Kolli, S. S.
    Cardwell, L. A.
    Richardson, I. M.
    Feldman, S. R.
    Pichardo, R. O.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (04) : 838 - 839